Papers
2
Total Citations
9
H-Index
2
About
Michihide Maeda is a leading gynecologic oncologist whose research is reshaping surgical approaches to complex malignancies. His work centers on two critical frontiers: the impact of hospital surgical volume on outcomes in minimally invasive surgery (MIS) and the advancement of robotic techniques for recurrent cervical cancer. In his pivotal 2021 study, Maeda exposed an "unmet need for evidence" in gynecologic MIS, demonstrating that higher hospital surgical volume correlates with improved survival and perioperative outcomes—a finding with 7 citations that challenges institutions to centralize care. More recently, his 2024 single-surgeon series pioneered a comparison of robotic-assisted versus open salvage radical hysterectomy for locally recurrent cervical cancer. By showing that robotic surgery can match or surpass conventional open approaches in both surgical and oncologic outcomes, Maeda is expanding treatment options for patients with limited alternatives. His work bridges the gap between technical innovation and real-world evidence, offering actionable insights for surgeons and policymakers. With each study, Maeda drives the field toward safer, more effective, and less invasive care for women facing gynecologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2